{'fraction_non_alphanumeric': 0.015717092337917484, 'fraction_numerical': 0.0, 'mean_word_length': 6.5, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Kaposi's Sarcoma in A Subject Treated for Dermatomyositis With Immunosuppressant and Steroid

The incidence of Kaposi's sarcoma has increased in recent years mainly because its association with the acquired immunodeficiency syndrome and organ transplant recipients treated with immunosuppressive drugs, especially with cyclosporine. We present the case of a patient with dermatomyositis who developed Kaposi's sarcoma after receiving treatment with steroids, cyclosporine, and human polyclonal immunoglobulin.